Patent ID: 7923544
Filing Date: 2011-04-12
Classification: C12Q

Abstract:
1. A biomarker consisting of between 7 and 35 different nucleic acid probe sets, wherein: (a) a first probe set consisting of one or more nucleotide probes consisting of 15 or more contiguous nucleotides of SEQ ID NO:5 (UBE2G1), or a full complement thereof; (b) a second probe set consisting of one or more nucleotide probes consisting of 15 or more contiguous nucleotides of SEQ ID NO:6 (CALM3), or a full complement thereof; (c) a third probe set consisting of one or more nucleotide probes consisting of 15 or more contiguous nucleotides of SEQ ID NO:9 (HIST1H2BK), or a full complement thereof; (d) a fourth probe set consisting of one or more nucleotide probes consisting of 15 or more contiguous nucleotides of SEQ ID NO:10 (PPP2R5A), or a full complement thereof; (e) a fifth probe set consisting of one or more nucleotide probes consisting of 15 or more contiguous nucleotides of—SEQ ID NO:3 (BLCAP), or a full complement thereof; and (f) a sixth probe set and a seventh probe set consisting of one or more nucleotide probes consisting of 15 or more contiguous nucleotides of a nucleic acid selected from the group consisting of wherein each of the between 7 and 35 different probe sets consists of one or more probes of 15 or more contiguous nucleotides, or full complements thereof, of a different mRNA, and wherein each of the different probe sets is optionally detectably labeled.